Serum stratifin measurement is useful for evaluating disease severity and outcomes in patients with acute exacerbation of interstitial lung disease: a retrospective study

Abstract Background Serum levels of stratifin (SFN), a member of the 14-3-3 protein family, increase in patients with drug-induced lung injury associated with diffuse alveolar damage. Therefore, we hypothesised that SFN levels would be higher in those experiencing acute exacerbation of interstitial...

Full description

Bibliographic Details

Published in:	BMC Pulmonary Medicine
Main Authors:	Noriko Sakuma, Mitsuhiro Abe, Daisuke Ishii, Takeshi Kawasaki, Noriaki Arakawa, Shinichiro Matsuyama, Yoshiro Saito, Takuji Suzuki, Koichiro Tatsumi
Format:	Article
Language:	English
Published:	BMC 2024-07-01
Subjects:	Stratifin Acute exacerbations Interstitial lung disease Biomarker
Online Access:	https://doi.org/10.1186/s12890-024-03184-6